Last updated: March 6, 2025
Sponsor: OHSU Knight Cancer Institute
Overall Status: Active - Not Recruiting
Phase
N/A
Condition
Esophageal Disorders
Digestive System Neoplasms
Esophageal Cancer
Treatment
Screening with swallowable esophageal cell-collection devices (SECD)
Clinical Study ID
NCT06335966
STUDY00025975
Ages > 50 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Signed informed consent
Willing and able to comply with the protocol
Live in a rural area
Chronic GERD Dx
3 or more of the following risk factors: Male, age >50 years White race Tobaccosmoking Obesity Family history of BE or EAC in a first-degree relative
Exclusion
Exclusion Criteria:
Study Design
Total Participants: 110
Treatment Group(s): 1
Primary Treatment: Screening with swallowable esophageal cell-collection devices (SECD)
Phase:
Study Start date:
September 11, 2024
Estimated Completion Date:
January 30, 2026
Study Description
Connect with a study center
OHSU Knight Cancer Institute
Portland, Oregon 97239
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.